Amundi Increases Stake in Charles River Laboratories International, Inc. $CRLMarket Beat·1 day ago, 02:12 AMCRL-0.90%LAZ+1.03%
Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared To CompetitorsMarketWatch Automated·Jul 29 at 04:16 PMCRL-0.90%
F5 Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily GainsMarketWatch Automated·Jul 24 at 04:06 PMFFIV+3.55%
Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading DayMarketWatch Automated·Jul 23 at 04:16 PMCRL-0.90%
Charles River Laboratories Earnings Preview: What to ExpectBarchart Option·Jul 20 at 10:48 AMCRL-0.90%
Charles River Laboratories International Inc. Stock Underperforms Friday When Compared To CompetitorsMarketWatch Automated·Jul 17 at 04:16 PMCRL-0.90%
How Charles River’s Expanded GMP NGS Role in ALA-101 Testing Will Impact Charles River (CRL) InvestorsSimplywall·Jul 17 at 08:08 AMCRL-0.90%
Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses On The DayMarketWatch Automated·Jul 15 at 04:15 PMCRL-0.90%
Charles River Labs updates financial calendar with second-quarter earnings release and conference callPUBT·Jul 15 at 07:00 AMCRL-0.90%
Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To CompetitorsMarketWatch Automated·Jul 13 at 04:16 PMCRL-0.90%
Charles River Laboratories , Inc. Stock 12‑Month Price Target Raised to $237.79, Implies 2% UpsideTradingView·Jul 13 at 11:20 AMCRL-0.90%
This Biogen Analyst Turns Bullish; Here Are Top 5 Upgrades For Mondaybenzinga_article·Jul 13 at 06:07 AMCOF-L-0.13%COF-J0.00%
Charles River to provide GMP NGS testing services to Arovella Therapeutics under new collaborationPUBT·Jul 13 at 07:01 AMCRL-0.90%
